• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型诱饵寡核苷酸的开发:环状哑铃形诱饵的优势

Development of novel decoy oligonucleotides: advantages of circular dumb-bell decoy.

作者信息

Tomita Naruya, Tomita Tetsuya, Yuyama Kazuhiko, Tougan Takahiro, Tajima Tsuyoshi, Ogihara Toshio, Morishita Ryuichi

机构信息

Department of Geriatric Medicine, Osaka University Graduate School of Medicine, Suita City, Osaka 565-0871, Japan.

出版信息

Curr Opin Mol Ther. 2003 Apr;5(2):107-12.

PMID:12772498
Abstract

The inhibition of specific transcription regulatory proteins is a novel approach to regulate gene expression. The transcriptional activities of DNA binding proteins can be inhibited by the use of double-stranded oligonucleotides (ODNs) that compete for binding to their specific target sequences in promoters and enhancers. Transfection of this cis-element double-stranded ODN, referred to as decoy ODN, has been reported to be a powerful tool that provides a new class of anti-gene strategies to gene therapy and permits examination of specific gene regulation. We have demonstrated the usefulness of this decoy ODN strategy in animal models of restenosis, myocardial infarction, glomerulonephritis and rheumatoid arthritis. However, one of the major limitations of decoy ODN technology is the rapid degradation of phosphodiester ODNs by intracellular nucleases. To date, several different types of double-stranded decoy ODNs have been developed to overcome this issue. Circular dumb-bell (CD) double-stranded decoy ODNs that were developed to resolve this issue have attracted a high level of interest. In this review, the applications of decoy ODN strategy and the advantages of modified CD double-stranded decoy ODNs will be discussed.

摘要

抑制特定转录调节蛋白是一种调控基因表达的新方法。通过使用双链寡核苷酸(ODN)可抑制DNA结合蛋白的转录活性,这些双链寡核苷酸能竞争结合启动子和增强子中的特定靶序列。据报道,转染这种顺式作用元件双链ODN(称为诱饵ODN)是一种强大的工具,为基因治疗提供了一类新的反基因策略,并可用于研究特定基因的调控。我们已经证明了这种诱饵ODN策略在再狭窄、心肌梗死、肾小球肾炎和类风湿性关节炎动物模型中的有效性。然而,诱饵ODN技术的主要局限性之一是磷酸二酯ODN会被细胞内核酶迅速降解。迄今为止,已开发出几种不同类型的双链诱饵ODN来克服这一问题。为解决此问题而开发的环状哑铃(CD)双链诱饵ODN引起了高度关注。在本综述中,将讨论诱饵ODN策略的应用以及修饰的CD双链诱饵ODN的优势。

相似文献

1
Development of novel decoy oligonucleotides: advantages of circular dumb-bell decoy.新型诱饵寡核苷酸的开发:环状哑铃形诱饵的优势
Curr Opin Mol Ther. 2003 Apr;5(2):107-12.
2
Potential therapeutic applications of decoy oligonucleotides.
Curr Opin Mol Ther. 2002 Apr;4(2):166-70.
3
Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia.新型E2F诱饵寡脱氧核苷酸抑制体外血管平滑肌细胞增殖和体内内膜增生。
Gene Ther. 2002 Dec;9(24):1682-92. doi: 10.1038/sj.gt.3301849.
4
Therapeutic potential of decoy oligonucleotides strategy in cardiovascular diseases.
Expert Rev Cardiovasc Ther. 2003 Sep;1(3):463-70. doi: 10.1586/14779072.1.3.463.
5
[Application of decoy strategy].
Nihon Rinsho. 1996 Sep;54(9):2583-90.
6
Gene therapy as a potential treatment for restenosis and myocardial infarction.基因治疗作为一种治疗再狭窄和心肌梗死的潜在方法。
Drug News Perspect. 2000 May;13(4):206-12.
7
In vivo transfection of a cis element 'decoy' against signal transducers and activators of transcription 6 (STAT6)-binding site ameliorates IgE-mediated late-phase reaction in an atopic dermatitis mouse model.针对信号转导及转录激活因子6(STAT6)结合位点的顺式作用元件“诱饵”在体内进行转染,可改善特应性皮炎小鼠模型中由免疫球蛋白E(IgE)介导的迟发相反应。
Gene Ther. 2004 Dec;11(24):1753-62. doi: 10.1038/sj.gt.3302341.
8
Molecular strategy using cis-element 'decoy' of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model.利用E2F结合位点顺式元件“诱饵”的分子策略抑制猪冠状动脉球囊损伤模型中的新生内膜形成。
Gene Ther. 2002 Apr;9(8):488-94. doi: 10.1038/sj.gt.3301679.
9
[The inhibitory effects of dumb-bell decoy oligodeoxynucleotides targeting NF-kappaB on the growth of multiple myeloma cells and IL-6 expression].[靶向NF-κB的哑铃状诱饵寡脱氧核苷酸对多发性骨髓瘤细胞生长及白细胞介素-6表达的抑制作用]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006 Jan;22(1):47-50.
10
Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotides.通过转录因子诱饵寡核苷酸抑制核因子κB激活的分子疗法。
Curr Opin Pharmacol. 2004 Apr;4(2):139-46. doi: 10.1016/j.coph.2003.10.008.

引用本文的文献

1
Decoy oligonucleotides targeting NF-κB: a promising therapeutic approach for inflammatory diseases.靶向核因子-κB的诱饵寡核苷酸:一种治疗炎症性疾病的有前景的方法。
Inflamm Res. 2025 Mar 6;74(1):47. doi: 10.1007/s00011-025-02021-8.
2
How far are the new wave of mRNA drugs from us? mRNA product current perspective and future development.mRNA 药物的新浪潮离我们还有多远?mRNA 产品的现状和未来发展。
Front Immunol. 2022 Sep 12;13:974433. doi: 10.3389/fimmu.2022.974433. eCollection 2022.
3
Decoy Technology as a Promising Therapeutic Tool for Atherosclerosis.
诱饵技术——动脉粥样硬化治疗的有前途的工具。
Int J Mol Sci. 2021 Apr 23;22(9):4420. doi: 10.3390/ijms22094420.
4
Regulation of transcription through light-activation and light-deactivation of triplex-forming oligonucleotides in mammalian cells.通过光激活和光失活三聚体形成寡核苷酸在哺乳动物细胞中转录的调控。
ACS Chem Biol. 2012 Jul 20;7(7):1247-56. doi: 10.1021/cb300161r. Epub 2012 May 11.
5
Transcription factor decoy oligonucleotide-based therapeutic strategy for renal disease.基于转录因子诱饵寡核苷酸的肾脏疾病治疗策略
Clin Exp Nephrol. 2007 Mar;11(1):7-17. doi: 10.1007/s10157-007-0459-6. Epub 2007 Mar 28.
6
Inhibitory effect of ribbon-type NF-kappaB decoy oligodeoxynucleotides on osteoclast induction and activity in vitro and in vivo.带状核因子-κB诱饵寡脱氧核苷酸对体内外破骨细胞诱导及活性的抑制作用
Arthritis Res Ther. 2006;8(4):R103. doi: 10.1186/ar1980.